Health Law Monitor

COVID-19 Update: Providers participating in COVID-19 clinical trials now eligible for MIPS credit

April 21, 2020

By: Alaina N. Crislip and

A recent announcement by the Centers for Medicare & Medicaid Services (CMS) provides that clinicians in the Quality Payment Program (QPP) are eligible to earn Merit-based Incentive Program System (MIPS) credit for participating in the “MIPS COVID-19 Clinical Trials” improvement activity. To receive credit for this new measure, clinicians must attest that they are participating in a COVID-19 clinical trial that utilizes a drug or biological product to treat COVID-19 patients and report their findings through a clinical data repository or clinical data registry for the duration of their study.

The April 20, 2020 press release can be found here.